Patents by Inventor Ryan McCormack

Ryan McCormack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10473270
    Abstract: Leak detection user interfaces are provided. In general, a user interface for a pipeline management system can be configured to provide information regarding one or more pipelines to a user. The information can include data gathered using one or more sensors sensing various parameters. The information on the user interface can include results of analysis of the gathered data, such as notifications that the gathered data indicates an anomaly with a pipeline. The notifications of anomalies can be provided on the user interface in real time with the data analysis. Accordingly, the user can trigger one or more corrective actions such as notifying maintenance personnel local to a location of the identified anomaly, remotely controlling the pipeline with the anomaly to close valve(s) and/or other equipment to prevent fluid flow in the pipeline in the area of the detected anomaly, etc.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: November 12, 2019
    Assignee: General Electric Company
    Inventors: Bruce J. Jacobson, Ryan McCormack, Gandeephan Ganeshalingam, Trent Gillham, Mauricio Palomino, Glen Peter Koste, Ehsan Jalilian
  • Publication number: 20180094775
    Abstract: Leak detection user interfaces are provided. In general, a user interface for a pipeline management system can be configured to provide information regarding one or more pipelines to a user. The information can include data gathered using one or more sensors sensing various parameters. The information on the user interface can include results of analysis of the gathered data, such as notifications that the gathered data indicates an anomaly with a pipeline. The notifications of anomalies can be provided on the user interface in real time with the data analysis. Accordingly, the user can trigger one or more corrective actions such as notifying maintenance personnel local to a location of the identified anomaly, remotely controlling the pipeline with the anomaly to close valve(s) and/or other equipment to prevent fluid flow in the pipeline in the area of the detected anomaly, etc.
    Type: Application
    Filed: September 29, 2017
    Publication date: April 5, 2018
    Inventors: Bruce J. Jacobson, Ryan McCormack, Gandeephan Ganeshalingam, Trent Gillham, Mauricio Palomino, Glen Koste, Ehsan Jalilian
  • Publication number: 20170191058
    Abstract: Perforin-2 (P2) is expressed by fibroblasts, microglia and macrophages and was found to be responsible for killing bacteria, for example, Mycobacteria smegmatis, M. avium, Salmonellae, MRSA (drug resistant Stapholococci), E. coli. Compounds identified by screening assays are selected based on the effects of these compounds on P2. Use of these compounds in the treatment of infectious diseases, in particular, bacteria and antibiotic-resistant bacteria is also provided.
    Type: Application
    Filed: September 1, 2016
    Publication date: July 6, 2017
    Inventors: Lesley De Armas, Kirill Lyapichev, Ryan McCormack, Eckhard Podack
  • Publication number: 20160250303
    Abstract: Methods and compositions are provided to modulate the activity of Perforin-2. Provided herein are various components of the Perforin-2 activation pathway. In specific embodiments, inhibitors of the various components of the Perforin-2 activation pathway are provided which may be employed in various methods, including, but not limited to, the diagnosis and treatment of diseases associated with gut inflammation. Methods of screening for Perforin-2 inhibitors are also provided. Further provided are compounds that increase the ubiquitination of Perforin-2 and thereby increase Perforin-2 activity. Various methods for increasing Perforin-2 activity and for the treatment of infectious disease, in particular bacteria and antibiotic-resistant bacteria, are also provided.
    Type: Application
    Filed: October 8, 2014
    Publication date: September 1, 2016
    Inventors: Eckhard R. Podack, Ryan McCormack
  • Publication number: 20160054299
    Abstract: Perforin-2 (P2) is expressed by fibroblasts, microglia and macrophages and was found to be responsible for killing bacteria, for example, Mycobacteria smegmatis, M. avium, Salmonellae, MRSA (drug resistant Stapholococci), E coli. Compounds identified by screening assays are selected based on the effects of these compounds on P2. Use of these compounds in the treatment of infectious diseases, in particular, bacteria and antibiotic-resistant bacteria is also provided.
    Type: Application
    Filed: March 15, 2013
    Publication date: February 25, 2016
    Inventors: Lesley De Armas, Kirill Lyapichev, Ryan McCormack, Eckhard Podack
  • Publication number: 20150204845
    Abstract: Perforin-2 (P2) is expressed by fibroblasts, microglia and macrophages and was found to be responsible for killing bacteria, for example, Mycobacteria smegmatis, M. avium, Salmonellae, MRSA (drug resistant Stapholococci), E coli. Compounds identified by screening assays are selected based on the effects of these compounds on P2. Use of these compounds in the treatment of infectious diseases, in particular, bacteria and antibiotic-resistant bacteria is also provided.
    Type: Application
    Filed: March 15, 2013
    Publication date: July 23, 2015
    Inventors: Lesley De Armas, Kirill Lyapichev, Ryan McCormack, Eckhard Podack
  • Publication number: 20070016864
    Abstract: A system and method for enriching memories and enhancing emotions about a specific personal event is disclosed. The system allows an easy to use enrichment of memories in terms of emotions and feelings around personal events such as vacations, promotions, sports, celebrations, etc. in form of still images, illustrations, templates, audio, video, and/or data. The invention is a turn-key system that combines broadly available hardware, industrial design, software, proprietary content, user-friendly user interface, distribution, and services tailored towards emotional personal events.
    Type: Application
    Filed: March 9, 2006
    Publication date: January 18, 2007
    Inventors: Bernard Kummerli, Jeffrey Smith, Selwyn Wan, Steve Israelson, Ryan McCormack, Henry Wier
  • Patent number: D1017805
    Type: Grant
    Filed: December 27, 2021
    Date of Patent: March 12, 2024
    Assignee: Entellus Medical, Inc.
    Inventors: Adrian O'Heney, Anthony J. Hanson, Ryan Cerepak, Eoghan McCormack, Aaron Swandal, John Drontle